El Dipòsit Digital ha actualitzat el programari. Contacteu amb dipositdigital@ub.edu per informar de qualsevol incidència.

 
Miniatura

Fitxers

658581.pdf (921.87 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2016-08
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/103583

A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism

Títol de la revista

Autors

ISSN de la revista

Títol del volum

Resum

Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplant. We designed this 12-month, prospective, multicenter, open-label, randomized study to evaluate whether subtotal parathyroidectomy is more effective than cinacalcet for controlling hypercalcemia caused by persistent hyperparathyroidism after kidney transplant. Kidney allograft recipients with hypercalcemia and elevated intact parathyroid hormone (iPTH) concentration were eligible if they had received a transplant ≥6 months before the study and had an eGFR>30 ml/min per 1.73 m2. The primary end point was the proportion of patients with normocalcemia at 12 months. Secondary end points were serum iPTH concentration, serum phosphate concentration, bone mineral density, vascular calcification, renal function, patient and graft survival, and economic cost. In total, 30 patients were randomized to receive cinacalcet (n=15) or subtotal parathyroidectomy (n=15). At 12 months, ten of 15 patients in the cinacalcet group and 15 of 15 patients in the parathyroidectomy group (P=0.04) achieved normocalcemia. Normalization of serum phosphate concentration occurred in almost all patients. Subtotal parathyroidectomy induced greater reduction of iPTH and associated with a significant increase in femoral neck bone mineral density; vascular calcification remained unchanged in both groups. The most frequent adverse events were digestive intolerance in the cinacalcet group and hypocalcemia in the parathyroidectomy group. Surgery would be more cost effective than cinacalcet if cinacalcet duration reached 14 months. All patients were alive with a functioning graft at the end of follow-up. In conclusion, subtotal parathyroidectomy was superior to cinacalcet in controlling hypercalcemia in these patients with kidney transplants and persistent hyperparathyroidism.

Descripció

Matèries

Calci en l'organisme, Trasplantament renal, Paratiroïdectomia, Ronyó, Hiperparatiroïdisme

Matèries (anglès)

Calcium in the body, Kidney transplantation, Parathyroidectomy, Kidney, Hyperparathyroidism

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

CRUZADO, Josep ma., MORENO LLORENTE, Pablo, TORREGROSA PRATS, José vicente, TACO, Omar, MAST, Richard, GÓMEZ VAQUERO, Carmen, POLO, Carolina, REVUELTA, Ignacio, FRANCOS MARTÍNEZ, José manuel, TORRAS AMBRÒS, Joan, GRACIA BARRASA, Arantxa, BESTARD MATAMOROS, Oriol, GRINYÓ BOIRA, Josep m.. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. _Journal of the American Society of Nephrology_. 2016. Vol. 27, núm. 8, pàgs. 2487-2494. [consulta: 26 de novembre de 2025]. ISSN: 1046-6673. [Disponible a: https://hdl.handle.net/2445/103583]

Exportar metadades

JSON - METS

Compartir registre